Hos patienter med psoriasis var den laveste gennemsnitlige steady- state- koncentration 5 µg/ ml ved behandling med adalimumab 40 mg i monoterapi hver anden uge.
In patients with psoriasis, the mean steady-state trough concentration was 5 µg/ mL during adalimumab 40 mg every other week monotherapy treatment.